 |
| ||
| Join/Renew Contact ONS Terms of Use FAQ | |||
| HOME |  |
CNE Central | |
Clinical Practice | |
Membership | |
Patient Education | |
Publications | |
Research |
| About ONS |
| Shop, Join, Register |
| Career Center |
| Legislative Action Center |
| Global Affairs |
| Oncology News |
| Awards, Grants, Scholarships |
| Commercial Support |
| Media Center |
| From the Editor |
|
ONS Profile |
FDA Communications
New Cancer Drug Approvals/FDA Updates
In collaboration with the Food and Drug Administration, ONS provides its members with information about newly approved therapies for patients with cancer via email. When such a communication is issued, ONS will immediately send an email indicating the nature of the communication and provide a link to the full text of the communication. This will include information from the product label to provide relevant clinical information on the indication, contraindications, dosing, and safety. Below is a list of archived communications.
| Date Sent | Manufacturer | Drug | Additional Information |
| May 30, 2007 | Wyeth, Inc. | TORISEL™ | |
| May 17, 2007 | Alza Corporation | DOXIL® | |
| May 1, 2007 | Pfizer, Inc. | Fragmin® | |
| March 16, 2007 | Alexion Pharmaceuticals, Inc. | Soliris™ | |
| March 13, 2007 | GlaxoSmithKline | Tykerb® | |
| December 08, 2006 | Millennium Pharmaceuticals, Inc. | Velcade® | |
| November 20, 2006 | Genentech, Inc. | Herceptin® | |
| October 23, 2006 | Novartis Pharmaceuticals | Gleevec® | |
| October 18, 2006 | Sanofi-Aventis | Taxotere® Injection Concentrate | |
| October 11, 2006 | Genentech, Inc. | Avastin™ | |
| October 6, 2006 | Merck & Co., Inc. | Zolinza™ | |
| October 5, 2006 | Genentech, Inc. | Rituxan® | Two supplemental applications listed |
| September 27, 2006 | Genentech | Avastin | |
| September 27, 2006 | Amgen, Inc. | Vectibix™ | |
| September 27, 2006 | Novartis Pharmaceuticals | Gleevec® | |
| September 14, 2006 | Wyeth Pharmaceuticals Inc. | Neumega® (Oprelvekin) | |
| July 24, 2006 | Enzon Pharmaceuticals, Inc. | Oncaspar® | |
| July 14, 2006 | Eli Lilly and Company | Gemzar® | |
| June 29, 2006 | Celgene Corporation | REVLIMID® | |
| June 28, 2006 | Bristol-Myers Squibb | SPRYCEL(™) | |
| June 20, 2006 | Genentech | Avastin® | |
| June 16, 2006 | Merck & Co. | Gardasil® | |
| June 15, 2006 | GlaxoSmithKline | Hycamtin® | |
| May 26, 2006 | Celgene Corporation | THALOMID® | |
| May 03, 2006 | MGI Pharma, Inc | Dacogen® | |
| May 03, 2006 | several | Isotretinoin | |
| March 24, 2006 | Sanofi-Aventis | Taxotere® (Docetaxel) | |
| March 1, 2006 | Imclone Systems | Erbitux® (Cetuximab) | |
| February 10, 2006 | Genentech and IDEC Pharmaceuticals | Rituxan® (rituximab) | |
| January 26, 2006 | Pfizer, Inc. | SUTENT® capsules (sunitinib malate) | |
| January 3, 2006 | Celgene Corporation | Revlimid(™) (lenalidomide) | |
| December 29, 2005 | Novartis Pharmaceuticals Corporation | Femara® (letrozole) | |
| December 21, 2005 | Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc. | Nexavar® (sorafenib) | |
| September 30, 2005 | Pfizer Pharmaceuticals | Camptosar/UGT1A1 Molecular Test | UGT1A1 Package Insert |
| September 16, 2005 | ImClone Systems | Erbitux (cetuximab) | |
| August 3, 2005 | Pfizer Pharmaceuticals | Camptosar | |
| June 20, 2005 | AstraZeneca Pharmaceuticals | Gefitinib (Iressa(r)) | |
| June 16, 2005 | Hoffman-LaRoche Inc. | Xeloda®Tablets | |
| March 28, 2005 | Millennium Pharmaceuticals, Inc. | Velcade® | |
| March 16, 2005 | Schering Corporation | Temodar® |
If you are a member of ONS, and are not receiving these messages, you can adjust your email preferences by logging into your profile at https://profile.ons.org and then selecting "Preferences." If you do not have a profile, create one now.